Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients (2018)
- Authors:
- Arruda, Lucas C. M.
- Farias, Kelen Cristina Ribeiro Malmegrim de
- Lima Júnior, João Rodrigues
- Clave, Emmanuel
- Dias, Juliana Bernardes Elias
- Moraes, Daniela A.
- Douay, Corinne
- Fournier, Isabelle
- Moins-Teisserenc, Hélène
- Alberdi, Antônio José
- Covas, Dimas Tadeu
- Simões, Belinda Pinto
- Lansiaux, Pauline
- Oliveira, Maria Carolina
- Arruda, Lucas C. M.
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; SIMOES, BELINDA PINTO - FMRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; ARRUDA, LUCAS COELHO MARLIÉRE - FMRP ; LIMA JÚNIOR, JOÃO RODRIGUES - FCFRP ; DIAS, JULIANA BERNARDES ELIAS - FMRP ; MORAES, DANIELA APARECIDA DE - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1182/bloodadvances.2017011072
- Subjects: TRANSPLANTES; CÉLULAS-TRONCO; SISTEMA IMUNE; LINFÓCITOS T; TRANSPLANTE AUTÓLOGO; TIMO (GLÂNDULA ENDÓCRINA)
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2018
- Source:
- Título: Blood Advances
- ISSN: 2473-9529
- Volume/Número/Paginação/Ano: v. 2, n. 2, p. 126-141, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
ARRUDA, Lucas C. M. et al. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, v. 2, n. 2, p. 126-141, 2018Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017011072. Acesso em: 28 dez. 2025. -
APA
Arruda, L. C. M., Farias, K. C. R. M. de, Lima Júnior, J. R., Clave, E., Dias, J. B. E., Moraes, D. A., et al. (2018). Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients. Blood Advances, 2( 2), 126-141. doi:10.1182/bloodadvances.2017011072 -
NLM
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072 -
Vancouver
Arruda LCM, Farias KCRM de, Lima Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Oliveira MC. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients [Internet]. Blood Advances. 2018 ; 2( 2): 126-141.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1182/bloodadvances.2017011072 - Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
Informações sobre o DOI: 10.1182/bloodadvances.2017011072 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
